Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation among Finnish elderly and chronically ill—An interim analysis of a nationwide …
U Baum, E Poukka, AA Palmu, H Salo, TO Lehtonen… - PLoS …, 2021 - journals.plos.org
Background In Finland, both mRNA and adenovirus vector (AdV) Covid-19 vaccines have
been used after the vaccination campaign started on December 27, 2020. Vaccination of the …
been used after the vaccination campaign started on December 27, 2020. Vaccination of the …
Effectiveness of Covid-19 vaccination against risk of symptomatic infection, hospitalization, and death up to 9 months: a Swedish total-population cohort study
P Nordström, M Ballin, A Nordström - Hospitalization, and Death …, 2021 - papers.ssrn.com
Background: Whether vaccine effectiveness against Coronavirus disease 2019 (Covid-19)
lasts longer than 6 months is unclear. Methods: A retrospective cohort study was conducted …
lasts longer than 6 months is unclear. Methods: A retrospective cohort study was conducted …
[HTML][HTML] Short-term safety of COVID-19 mRNA vaccines with respect to all-cause mortality in the older population in Norway
PLD Ruiz, N Gunnes, JM Gran, Ø Karlstad, R Selmer… - Vaccine, 2023 - Elsevier
Background There have been concerns about COVID-19 vaccination safety among frail
older individuals. We investigated the relationship between COVID-19 mRNA vaccination …
older individuals. We investigated the relationship between COVID-19 mRNA vaccination …
Factors influencing COVID-19 vaccination uptake in an elderly sample in Poland
M Malesza, M Bozym - MedRxiv, 2021 - medrxiv.org
Backgrounds This research represents an investigation into potential predictors for the
uptake of the COVID-19 vaccination in Poland, following the instigation of policies to …
uptake of the COVID-19 vaccination in Poland, following the instigation of policies to …
High vaccine effectiveness against severe COVID-19 in the elderly in Finland before and after the emergence of Omicron
U Baum, E Poukka, T Leino, T Kilpi, H Nohynek… - BMC infectious …, 2022 - Springer
Background The elderly are highly vulnerable to severe COVID-19. Waning immunity and
emergence of Omicron have caused concerns about reduced effectiveness of COVID-19 …
emergence of Omicron have caused concerns about reduced effectiveness of COVID-19 …
Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022
B de Gier, L van Asten, TM Boere, A van Roon… - Vaccine, 2023 - Elsevier
Background We aimed to estimate vaccine effectiveness (VE) against COVID-19 mortality,
and to explore whether an increased risk of non-COVID-19 mortality exists in the weeks …
and to explore whether an increased risk of non-COVID-19 mortality exists in the weeks …
Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November …
J Starrfelt, AS Danielsen, EA Buanes, LK Juvet… - BMC medicine, 2022 - Springer
Background COVID-19 vaccines have been crucial in the pandemic response and
understanding changes in vaccines effectiveness is essential to guide vaccine policies …
understanding changes in vaccines effectiveness is essential to guide vaccine policies …
Efficacy of the Second COVID-19 Vaccine Booster Dose in the Elderly
C Mattiuzzi, G Lippi - Vaccines, 2023 - mdpi.com
Background: We analyzed coronavirus disease 2019 (COVID-19) vaccine efficacy in older
persons who received the second booster compared to unvaccinated people and those …
persons who received the second booster compared to unvaccinated people and those …
Efficacy of COVID-19 vaccine booster doses in older people
C Mattiuzzi, G Lippi - European Geriatric Medicine, 2022 - Springer
Purpose We provide here an updated analysis on efficacy of COVID-19 vaccine booster
doses in older people (ie, aged≥ 80 years) based on ongoing Italian nationwide COVID-19 …
doses in older people (ie, aged≥ 80 years) based on ongoing Italian nationwide COVID-19 …
COVID-19 vaccine effectiveness against hospitalizations and ICU admissions in the Netherlands, April-August 2021
B de Gier, M Kooijman, J Kemmeren, N de Keizer… - MedRxiv, 2021 - medrxiv.org
The objective of this study was to estimate vaccine effectiveness (VE) against COVID-19
hospitalization and ICU admission, per period according to dominating SARS-CoV-2 variant …
hospitalization and ICU admission, per period according to dominating SARS-CoV-2 variant …